Everolimus Related Pneumonitis in MBC
To study the drug-related pneumonitis during mTOR inhibitor therapy in patients with metastatic breast cancer.
Everolimus|Pneumonitis
radiographic pattern, Quantitive measure of lung CT, 2 months|PFS, Progression free survival, 2 months
To study the drug-related pneumonitis during mTOR inhibitor therapy in patients with metastatic breast cancer.